Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma

NCT03829969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy

Interventions

BIOLOGICAL: Toripalimab

Sponsor

Shanghai Junshi Bioscience Co., Ltd.